MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—establishing disease prognosis and monitoring patients

Defining high, medium and low impact prognostic factors for developing multiple sclerosis

(2015) Mar Tintore et al.   BRAIN

Subgroups of multiple sclerosis patients with larger treatment benefits: a meta-analysis of randomized trials

(2015) A. Signori et al.   EUROPEAN JOURNAL OF NEUROLOGY

Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients

(2015) Nicola De Stefano et al.   Multiple Sclerosis Journal

MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis—clinical implementation in the diagnostic process

(2015) Àlex Rovira et al.   Nature Reviews Neurology

PML in a Patient without Severe Lymphocytopenia Receiving Dimethyl Fumarate

(2015) Dennis J. Nieuwkamp et al.   NEW ENGLAND JOURNAL OF MEDICINE

PML in a Patient with Lymphocytopenia Treated with Dimethyl Fumarate

(2015) Thorsten Rosenkranz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Varicella-Zoster Virus Infections in Patients Treated With Fingolimod

(2015) Ann M. Arvin et al.   JAMA Neurology

Towards a better understanding of pseudoatrophy in the brain of multiple sclerosis patients

(2015) Nicola De Stefano et al.   Multiple Sclerosis Journal

Progressive multifocal leukoencephalopathy after natalizumab discontinuation: Few and true?

(2014) Mike P. Wattjes et al.   ANNALS OF NEUROLOGY

Anti-JC virus antibody levels in serum or plasma further define risk of natalizumab-associated progressive multifocal leukoencephalopathy

(2014) Tatiana Plavina et al.   ANNALS OF NEUROLOGY

Treatment Optimization in MS: Canadian MS Working Group Updated Recommendations

(2014) Mark S. Freedman et al.   CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES

Clinical Relevance of Brain Volume Measures in Multiple Sclerosis

(2014) Nicola De Stefano et al.   CNS DRUGS

Diagnosis of natalizumab-associated progressive multifocal leukoencephalopathy using MRI

(2014) Mike P. Wattjes et al.   CURRENT OPINION IN NEUROLOGY

Established and novel disease-modifying treatments in multiple sclerosis

(2014) A. H. Cross et al.   JOURNAL OF INTERNAL MEDICINE

Imaging outcomes for trials of remyelination in multiple sclerosis

(2014) Shahrukh Mallik et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

MRI pattern in asymptomatic natalizumab-associated PML

(2014) Mike P Wattjes et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The grey matter correlates of impaired decision-making in multiple sclerosis

(2014) Nils Muhlert et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Brain atrophy and disability progression in multiple sclerosis patients: a 10-year follow-up study

(2014) Cecilie Jacobsen et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Brain atrophy in natalizumab-treated patients: A 3-year follow-up

(2014) J Sastre-Garriga et al.   Multiple Sclerosis Journal

Diagnostic value of brain chronic black holes on T1-weighted MR images in clinically isolated syndromes

(2014) Raquel Mitjana et al.   Multiple Sclerosis Journal

Mean upper cervical cord area (MUCCA) measurement in long-standing multiple sclerosis: Relation to brain findings and clinical disability

(2014) Marita Daams et al.   Multiple Sclerosis Journal

Evaluating the response to glatiramer acetate in relapsing–remitting multiple sclerosis (RRMS) patients

(2014) Jordi Río et al.   Multiple Sclerosis Journal

Towards the implementation of ‘no evidence of disease activity’ in multiple sclerosis treatment: the multiple sclerosis decision model

(2014) Martin Stangel et al.   Therapeutic Advances in Neurological Disorders

Outcome and survival of asymptomatic PML in natalizumab-treated MS patients

(2014) Tuan Dong-Si et al.   Annals of Clinical and Translational Neurology

Treatment effect on brain atrophy correlates with treatment effect on disability in multiple sclerosis

(2013) Maria Pia Sormani et al.   ANNALS OF NEUROLOGY

Progressive multifocal leukoencephalopathy after natalizumab discontinuation

(2013) Andrew J. Fine et al.   ANNALS OF NEUROLOGY

Requirement for safety monitoring for approved multiple sclerosis therapies: an overview

(2013) P. S. Rommer et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients

(2013) M. Romeo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Automated identification of brain new lesions in multiple sclerosis using subtraction images

(2013) Marco Battaglini et al.   JOURNAL OF MAGNETIC RESONANCE IMAGING

Ultra-high field MRI: looking through the 'macroscope'

(2013) I. D. Kilsdonk et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Brain atrophy and lesion load predict long term disability in multiple sclerosis

(2013) Veronica Popescu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Changes to anti-JCV antibody levels in a Swedish national MS cohort

(2013) Clemens Warnke et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Ultra-high-field MR imaging in multiple sclerosis

(2013) M. Filippi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Placebo-controlled trial of oral laquinimod in multiple sclerosis: MRI evidence of an effect on brain tissue damage

(2013) M. Filippi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Future MRI tools in multiple sclerosis

(2013) M. Filippi et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Clinical and magnetic resonance imaging predictors of disease progression in multiple sclerosis: a nine-year follow-up study

(2013) L Lavorgna et al.   Multiple Sclerosis Journal

Interferon beta-1b reduces black holes in a randomised trial of clinically isolated syndrome

(2013) Gijsbert JA Nagtegaal et al.   Multiple Sclerosis Journal

Relevance of hypointense brain MRI lesions for long-term worsening of clinical disability in relapsing multiple sclerosis

(2013) Antonio Giorgio et al.   Multiple Sclerosis Journal

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes

(2013) Angela Vidal-Jordana et al.   Multiple Sclerosis Journal

Interferon beta failure predicted by EMA criteria or isolated MRI activity in multiple sclerosis

(2013) Luca Prosperini et al.   Multiple Sclerosis Journal

The chameleon of neuroinflammation: magnetic resonance imaging characteristics of natalizumab-associated progressive multifocal leukoencephalopathy

(2013) Mike P Wattjes et al.   Multiple Sclerosis Journal

Clinical impact of early brain atrophy in clinically isolated syndromes

(2013) F Pérez-Miralles et al.   Multiple Sclerosis Journal

Influence of the topography of brain damage on depression and fatigue in patients with multiple sclerosis

(2013) C Gobbi et al.   Multiple Sclerosis Journal

Defining and scoring response to IFN-β in multiple sclerosis

(2013) Maria Pia Sormani et al.   Nature Reviews Neurology

Guidelines from The Italian Neurological and Neuroradiological Societies for the use of magnetic resonance imaging in daily life clinical practice of multiple sclerosis patients

(2013) Massimo Filippi et al.   NEUROLOGICAL SCIENCES

Tumefactive MS lesions under fingolimod: A case report and literature review

(2013) G. Pilz et al.   NEUROLOGY

Gray matter damage predicts the accumulation of disability 13 years later in MS

(2013) M. Filippi et al.   NEUROLOGY

PML in a Patient Treated with Dimethyl Fumarate from a Compounding Pharmacy

(2013) Bob W. van Oosten et al.   NEW ENGLAND JOURNAL OF MEDICINE

Novel therapeutic options for multiple sclerosis

(2013) François Curtin et al.   Expert Review of Clinical Pharmacology

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy

(2012) Tarek A. Yousry et al.   ANNALS OF NEUROLOGY

Cortical lesion load associates with progression of disability in multiple sclerosis

(2012) M. Calabrese et al.   BRAIN

Current Treatment Strategies for Multiple Sclerosis - Efficacy Versus Neurological Adverse Effects

(2012) Martin S. Weber et al.   CURRENT PHARMACEUTICAL DESIGN

Improved detection of cortical MS lesions with phase-sensitive inversion recovery MRI

(2012) Varun Sethi et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Association between pathological and MRI findings in multiple sclerosis

(2012) Massimo Filippi et al.   LANCET NEUROLOGY

Magnetization transfer imaging in multiple sclerosis treated with alemtuzumab

(2012) T. Button et al.   Multiple Sclerosis Journal

Scoring treatment response in patients with relapsing multiple sclerosis

(2012) MP Sormani et al.   Multiple Sclerosis Journal

Risk stratification for progressive multifocal leukoencephalopathy in patients treated with natalizumab

(2012) Per Soelberg Sørensen et al.   Multiple Sclerosis Journal

Neuroprotection and repair in multiple sclerosis

(2012) Robin J. M. Franklin et al.   Nature Reviews Neurology

Inflammation High-Field Magnetic Resonance Imaging

(2012) Iris D. Kilsdonk et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Simultaneous PML-IRIS after discontinuation of natalizumab in a patient with MS

(2012) S. Gheuens et al.   NEUROLOGY

Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod

(2012) J. N. Ratchford et al.   NEUROLOGY

Spinal cord lesions in patients with clinically isolated syndrome: A powerful tool in diagnosis and prognosis

(2012) M. H. Sombekke et al.   NEUROLOGY

Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod

(2012) C. M. Gross et al.   NEUROLOGY

Tumefactive multiple sclerosis lesions under fingolimod treatment

(2012) F. Visser et al.   NEUROLOGY

Risk of Natalizumab-Associated Progressive Multifocal Leukoencephalopathy

(2012) Gary Bloomgren et al.   NEW ENGLAND JOURNAL OF MEDICINE

Revisiting Brain Atrophy and Its Relationship to Disability in Multiple Sclerosis

(2012) Navid Shiee et al.   PLoS One

Reliability of Classifying Multiple Sclerosis Disease Activity Using Magnetic Resonance Imaging in a Multiple Sclerosis Clinic

(2012) Ebru Erbayat Altay et al.   JAMA Neurology

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis

(2011) David B. Clifford   ARCHIVES OF NEUROLOGY

Cortical pathology and cognitive impairment in multiple sclerosis

(2011) Massimiliano Calabrese et al.   Expert Review of Neurotherapeutics

Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

(2011) Ludwig Kappos et al.   LANCET NEUROLOGY

Intracortical lesions by 3T magnetic resonance imaging and correlation with cognitive impairment in multiple sclerosis

(2011) Flavia Nelson et al.   Multiple Sclerosis Journal

MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials

(2011) Frederik Barkhof et al.   Nature Reviews Neurology

Consensus recommendations for MS cortical lesion scoring using double inversion recovery MRI

(2011) J. J. G. Geurts et al.   NEUROLOGY

Improved in vivo detection of cortical lesions in multiple sclerosis using double inversion recovery MR imaging at 3 Tesla

(2010) Birgit Simon et al.   EUROPEAN RADIOLOGY

A method for evaluating treatment switching criteria in multiple sclerosis

(2010) Brian C Healy et al.   Multiple Sclerosis Journal

Magnetic resonance active lesions as individual-level surrogate for relapses in multiple sclerosis

(2010) Maria Pia Sormani et al.   Multiple Sclerosis Journal

Early MRI in optic neuritis: the risk for clinically definite multiple sclerosis

(2010) JK Swanton et al.   Multiple Sclerosis Journal

Brainstem lesions in clinically isolated syndromes

(2010) M. Tintore et al.   NEUROLOGY

Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes

(2010) N. De Stefano et al.   NEUROLOGY

Improved Detection of Active Multiple Sclerosis Lesions: 3D Subtraction Imaging

(2010) Bastiaan Moraal et al.   RADIOLOGY

Quantitative MR Imaging of Brain Iron: A Postmortem Validation Study

(2010) Christian Langkammer et al.   RADIOLOGY

Progressive Multifocal Leukoencephalopathy Following Heightened Immunosuppression After Lung Transplant

(2009) Jesse Waggoner et al.   JOURNAL OF HEART AND LUNG TRANSPLANTATION

Accumulation of cortical lesions in MS: relation with cognitive impairment

(2009) SD Roosendaal et al.   Multiple Sclerosis Journal

Measures in the first year of therapy predict the response to interferon β in MS

(2009) J Río et al.   Multiple Sclerosis Journal

Imaging outcomes for neuroprotection and repair in multiple sclerosis trials

(2009) Frederik Barkhof et al.   Nature Reviews Neurology

Predicting responders to therapies for multiple sclerosis

(2009) Jordi Río et al.   Nature Reviews Neurology

Intra- and interscanner variability of automated voxel-based volumetry based on a 3D probabilistic atlas of human cerebral structures

(2009) Hans-Jürgen Huppertz et al.   NEUROIMAGE

Early MRI in optic neuritis: The risk for disability

(2009) J. K. Swanton et al.   NEUROLOGY

HEMORRHAGING FOCAL ENCEPHALITIS UNDER FINGOLIMOD (FTY720) TREATMENT: A CASE REPORT

(2009) F. Leypoldt et al.   NEUROLOGY

Gray matter atrophy in multiple sclerosis: A longitudinal study

(2008) Elizabeth Fisher et al.   ANNALS OF NEUROLOGY

Magnetization transfer ratio evolution with demyelination and remyelination in multiple sclerosis lesions

(2008) Jacqueline T. Chen et al.   ANNALS OF NEUROLOGY

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

(2008) L. K. Fisniku et al.   BRAIN

Grey matter pathology in multiple sclerosis

(2008) Jeroen JG Geurts et al.   LANCET NEUROLOGY

Relationship between MRI lesion activity and response to IFN-β in relapsing–remitting multiple sclerosis patients

(2008) J Río et al.   Multiple Sclerosis Journal

Diffusion Tensor MR Imaging

(2008) Marco Rovaris et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Magnetization Transfer MR Imaging in Multiple Sclerosis

(2008) Stefan Ropele et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Proton Magnetic Resonance Spectroscopy in Multiple Sclerosis

(2008) Balasrinivasa R. Sajja et al.   NEUROIMAGING CLINICS OF NORTH AMERICA

Mechanisms of action of disease-modifying agents and brain volume changes in multiple sclerosis

(2008) R. Zivadinov et al.   NEUROLOGY

Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study

(2007) B.R. Sajja et al.   Multiple Sclerosis Journal